Related Experiment Videos

The CHARM program: study design leads to findings of clinical and public health importance

Charles H Hennekens1, Marc A Pfeffer, Karl Swedberg

  • 1Florida Atlantic University, Boca Raton, Florida, and Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.

Journal of Cardiovascular Pharmacology and Therapeutics
|June 15, 2007
PubMed

Insights

The CHARM trials show that candesartan, an angiotensin-receptor blocker, offers significant benefits for heart failure patients. This drug effectively reduces mortality and hospitalizations, whether used alone or with other heart failure medications.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Heart failure (HF) is a leading cause of hospitalization and mortality in older adults.
  • Beta-adrenergic blockers and angiotensin-converting enzyme inhibitors (ACEIs) offer proven benefits in HF treatment.
  • There is a need for alternative or additional therapies to further improve outcomes in HF patients.

Purpose of the Study:

  • To evaluate the efficacy and safety of candesartan, an angiotensin-receptor blocker (ARB), in patients with heart failure.
  • To determine if candesartan provides additive benefits to existing therapies like ACEIs and beta-adrenergic blockers.
  • To assess the impact of candesartan on cardiovascular mortality and heart failure hospitalizations.

Main Methods:

  • The CHARM (Candesartan in Heart Failure) program comprised multiple randomized trials.
  • Patients with heart failure received candesartan as an alternative or in addition to ACEIs.
  • A significant proportion of participants (55%) were also treated with beta-adrenergic blockers.

Main Results:

  • Candesartan demonstrated statistically significant and clinically important benefits in reducing mortality and morbidity in heart failure patients.
  • The addition or substitution of candesartan proved effective and safe when used with ACEIs.
  • Significant reductions in cardiovascular mortality and heart failure hospitalizations were observed.

Conclusions:

  • Angiotensin-receptor blockers, specifically candesartan, are effective and safe therapies for heart failure management.
  • Candesartan provides additive benefits when used as an alternative or in addition to ACEIs in heart failure patients.
  • These findings support the use of ARBs to improve outcomes in the broad spectrum of heart failure patients, including those on beta-blockers.

Related Concept Videos

Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Introduction to Epidemiology01:26

Introduction to Epidemiology

Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Study Design in Statistics01:15

Study Design in Statistics

A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...